Neuraminidase-Mediated, NKp46-Dependent Immune-Evasion Mechanism of Influenza Viruses

Cell Reports

Volumn 3, Issue 4, 2013, Pages 1044-1050

  Bar On, Yotam ^a   Glasner, Ariella ^a   Meningher, Tal ^b,c   Achdout, Hagit ^a,d   Gur, Chamutal ^a   Lankry, Dikla ^a   Vitenshtein, Alon ^a   Meyers, AdrienneF A ^e,f   Mandelboim, Michal ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

^d ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; OSELTAMIVIR; SIALIC ACID; SIALIDASE; SIALIDASE INHIBITOR; ZANAMIVIR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNE EVASION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INFLUENZA VIRUS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS RELEASE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, LY; CELL LINE, TUMOR; ENZYME INHIBITORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNE EVASION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; KILLER CELLS, NATURAL; MICE; MICE, KNOCKOUT; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NEURAMINIDASE; ORTHOMYXOVIRIDAE; OSELTAMIVIR;

ORTHOMYXOVIRIDAE;

EID: 84876980838     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.03.034     Document Type: Article

References (21)

1. Achdout H., Arnon T.I., Markel G., Gonen-Gross T., Katz G., Lieberman N., Gazit R., Joseph A., Kedar E., Mandelboim O. Enhanced recognition of human NK receptors after influenza virus infection. J.Immunol. 2003, 171:915-923.
2. Achdout H., Meningher T., Hirsh S., Glasner A., Bar-On Y., Gur C., Porgador A., Mendelson M., Mandelboim M., Mandelboim O. Killing of avian and Swine influenza virus by natural killer cells. J.Virol. 2010, 84:3993-4001.
3. Arnon T.I., Lev M., Katz G., Chernobrov Y., Porgador A., Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 2001, 31:2680-2689.
4. Arnon T.I., Achdout H., Lieberman N., Gazit R., Gonen-Gross T., Katz G., Bar-Ilan A., Bloushtain N., Lev M., Joseph A., et al. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 2004, 103:664-672.
5. Dolin R. Resistance to neuraminidase inhibitors. Clin. Infect. Dis. 2011, 52:438-439.
6. Gazit R., Gruda R., Elboim M., Arnon T.I., Katz G., Achdout H., Hanna J., Qimron U., Landau G., Greenbaum E., et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006, 7:517-523.
7. Glasner A., Zurunic A., Meningher T., Lenac Rovis T., Tsukerman P., Bar-On Y., Yamin R., Meyers A.F., Mandeboim M., Jonjic S., Mandelboim O. Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One 2012, 7:e36837.
8. Hindiyeh M., Levy V., Azar R., Varsano N., Regev L., Shalev Y., Grossman Z., Mendelson E. Evaluation of a multiplex real-time reverse transcriptase PCR assay for detection and differentiation of influenza viruses A and B during the 2001-2002 influenza season in Israel. J.Clin. Microbiol. 2005, 43:589-595.
9. Ho J.W., Hershkovitz O., Peiris M., Zilka A., Bar-Ilan A., Nal B., Chu K., Kudelko M., Kam Y.W., Achdout H., et al. H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J.Virol. 2008, 82:2028-2032.
10. Jefferson T., Jones M., Doshi P., Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009, 339:b5106.
11. Lindemann L., Jacobsen H., Schuhbauer D., Knoflach F., Gatti S., Wettstein J.G., Loetscher H., Chu T., Ebeling M., Paulson J.C., et al. Invitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu) and active metabolite. Eur. J. Pharmacol. 2010, 628:6-10.
12. Lubinski J.M., Wang L., Soulika A.M., Burger R., Wetsel R.A., Colten H., Cohen G.H., Eisenberg R.J., Lambris J.D., Friedman H.M. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion invivo. J.Virol. 1998, 72:8257-8263.
13. Mandelboim O., Reyburn H.T., Valés-Gómez M., Pazmany L., Colonna M., Borsellino G., Strominger J.L. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J.Exp. Med. 1996, 184:913-922.
14. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001, 409:1055-1060.
15. Mendelson M., Tekoah Y., Zilka A., Gershoni-Yahalom O., Gazit R., Achdout H., Bovin N.V., Meningher T., Mandelboim M., Mandelboim O., et al. NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J.Virol. 2010, 84:3789-3797.
16. Nayak D.P., Hui E.K., Barman S. Assembly and budding of influenza virus. Virus Res. 2004, 106:147-165.
17. Rifkin D.B., Quigley J.P. Virus-induced modification of cellular membranes related to viral structure. Annu. Rev. Microbiol. 1974, 28:325-351.
18. Rossman J.S., Lamb R.A. Influenza virus assembly and budding. Virology 2011, 411:229-236.
19. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., Fukuda K. Influenza-associated hospitalizations in the United States. JAMA 2004, 292:1333-1340.
20. Verma A., White M., Vathipadiekal V., Tripathi S., Mbianda J., Ieong M., Qi L., Taubenberger J.K., Takahashi K., Jensenius J.C., et al. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses. J.Immunol. 2012, 189:2478-2487.
21. Wang X., Hinson E.R., Cresswell P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2007, 2:96-105.